Analyst Price Targets — AQB
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 16, 2024 8:40 am | Ben Klieve | Lake Street | $2.00 | $2.00 | TheFly | AquaBounty price target lowered to $2 from $3 at Lake Street |
| May 15, 2024 8:44 am | Chris Krueger | Loop Capital Markets | $4.00 | $2.02 | StreetInsider | AquaBounty Technologies (AQB) PT Lowered to $4 at Lake Street Capital Markets |
Latest News for AQB
AquaBounty Technologies, Inc. (NASDAQ: AQB - Get Free Report) was the target of a significant drop in short interest during the month of January. As of January 30th, there was short interest totaling 17,318 shares, a drop of 25.9% from the January 15th total of 23,366 shares. Approximately 0.5% of the shares of the company are
AquaBounty Technologies (NASDAQ: AQB - Get Free Report) and Tyra Biosciences (NASDAQ: TYRA - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk and profitability. Institutional and Insider Ownership 8.9% of AquaBounty
AquaBounty Technologies, Inc. (NASDAQ: AQB - Get Free Report) was the target of a significant decline in short interest in the month of December. As of December 15th, there was short interest totaling 11,813 shares, a decline of 48.8% from the November 30th total of 23,090 shares. Currently, 0.3% of the shares of the stock are
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AQB.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.